Cell-based assays for immuno-oncology

 

Scientists are actively discovering, testing, and validating a range of immunotherapeutic agents that precisely target specific organs or cell types and trigger robust and safe immune responses. As immunotherapies become increasingly complex and specialized, cellular assays that assess drug immunogenicity and immunotoxicity are crucial for researchers to gain deeper insights into tumor-immune interactions and therapy effectiveness.